(Q42023933)

15 October 2017

Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients (English)

1 reference

Streptococcus milleri group

15 October 2017

0 references

1 reference

object named as

Streptococcus milleri

1 reference

6

Michael G Surette

1 reference

15 October 2017

Margot E Grinwis

1

1 reference

15 October 2017

Christopher D Sibley

2

1 reference

15 October 2017

Michael D Parkins

3

1 reference

15 October 2017

Christina S Eshaghurshan

4

1 reference

15 October 2017

Harvey R Rabin

5

1 reference

15 October 2017

language of work or name

English

0 references

publication date

19 April 2010

1 reference

15 October 2017

7

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

15 October 2017

54

1 reference

15 October 2017

7

1 reference

15 October 2017

2823-2829

1 reference

Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

The Streptococcus milleri group--an unrecognized cause of disease in cystic fibrosis: a case series and literature review

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Retrospective analysis of 49 cases of brain abscess and review of the literature

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Clinically significant infections with organisms of the Streptococcus milleri group

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Trends in antimicrobial susceptibility of the Streptococcus milleri group

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ("S. milleri") group

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Acute bronchopulmonary infection due to Streptococcus milleri in a child with cystic fibrosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Species belonging to the "Streptococcus milleri" group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Erythromycin resistance by ribosome modification

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Streptococcus milleri pulmonary disease: a review and clinical description of 25 patients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Microbiology of pyogenic liver abscess.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Bacteriology of abscesses of the central nervous system: a multicentre prospective study

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in Germany

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Relevance of group Milleri streptococci in thoracic surgery: a clinical update.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Five-year analysis of antimicrobial susceptibility of the Streptococcus milleri group

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Prospective study of Streptococcus milleri hepatic abscess

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Efficacy of aerosolized tobramycin in patients with cystic fibrosis.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Thoracic Empyema in Patients with Community-Acquired Pneumonia

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Antimicrobial Susceptibilities of Species of Viridans Streptococci

30 September 2018

1 reference

12 December 2020

Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection

1 reference

12 December 2020

Bacteriologic characteristics and antimicrobial susceptibility of 70 clinically significant isolates of Streptococcus milleri group

1 reference

12 December 2020

The Streptococcus milleri group as a cause of pulmonary infections

1 reference

12 December 2020

Thoracic infection caused by Streptococcus milleri

1 reference

12 December 2020

A study of susceptibility of 100 clinical isolates belonging to the Streptococcus milleri group to 16 cephalosporins

1 reference

12 December 2020

Aetiological agents, interleukin-6, interleukin-8 and CRP concentrations in children with community- and hospital-acquired pneumonia

1 reference

12 December 2020

Clinical analysis of cases of empyema due to Streptococcus milleri group

1 reference

12 December 2020

McKay agar enables routine quantification of the 'Streptococcus milleri' group in cystic fibrosis patients

1 reference

12 December 2020

Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosis

1 reference

12 December 2020

The importance of recognising Streptococcus milleri as a cause of orbital cellulitis

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.01845-09

1 reference

15 October 2017

1 reference

15 October 2017

PubMed publication ID

20404127

1 reference